This study used Finnish juvenile idiopathic arthritis (JIA) probands with pauciarticular and rheumatoid factor (RF) negative polyarticular subtypes of JIA to further define the genetic susceptibility to JIA. We examined 16 markers spanning an 18 cM region of chromosome 6 encompassing the MHC and surrounding genomic region in a set of 235 Finnish JIA nuclear families and 639 Finnish control individuals. Analysis by case/control association and transmission disequilibrium test (TDT) methods each demonstrated strong evidence for a susceptibility locus near the D6S2447 microsatellite (Po10 À6 for both methods) that is flanked by DQB1 and DRB1. Analysis of the DRB1 locus suggested that DRB1*0801 and DRB1*1101 rather than DQA1 or other HLA alleles may be responsible for conferring susceptibility to disease. These findings are consistent with the most compelling results of previous reports on HLA associations and suggest a JIA DRB1 shared epitope encompassing critical amino-acid residues in the third hypervariable region of this molecule. Most importantly, in pauciarticular patients, the strong association does not extend to proximal markers as it does in polyarticular patients (Po0.00001). Analysis strongly suggests that the difference is because of additional JIA susceptibility loci within the MHC being present in polyarticular RF negative patients.
Introduction
Juvenile idiopathic arthritis (JIA), formerly called juvenile rheumatoid arthritis (JRA) or juvenile chronic arthritis (JCA), is defined as arthritis of unknown cause of at least 6 weeks duration starting before the patient's 16th birthday. 1 Several subgroups of JIA are recognized and they differ in clinical manifestations, prognosis, specific autoimmune features, and genetic determinants. Ethnic differences exist according to subgroups and gender. In Western societies, the annual incidence of JIA is 10-20/100 000 in the pediatric population and the prevalence is about 1/1000. 2 Pauciarticular types of onset predominate, comprising about 60% of patients. The proportion of rheumatoid factor (RF) negative polyarthritis is about 30%.
JIA is a complex genetic disease for which there is evidence supporting both genetic and environmental effects. It is nonetheless commonly believed that the risk to a sibling with JIA is not particularly strong, as evidenced by the rarity of reported extended multiplex families. 3 Yet our recent data provided evidence that the genetic component in JIA is more marked than previously believed, 4 certainly much higher than in adult rheumatoid arthritis (RA).
The first HLA associations with JIA were reported in 1979/80. 5, 6 No specific locus has shown direct, definitive involvement in the pathogenesis of JIA. However, over 50 studies comprising different population groups have shown some consistent association of HLA loci with specific subtypes of disease (see reviews in Glass and Giannini 3 , Albert et al, 7 Nepom 8 , Howard et al 9 and Forre and Smerdel 10 ). The most convincing genetic associations involve the DRB1, DQA1, DQB1, and DPB1 HLA genes on chromosome 6. However, there is disagreement over the importance and implications of specific HLA associations in JIA. The frequency of HLA alleles varies widely between populations and differences in HLA typing methodologies can make HLA comparisons 'inexact'.
Associations in European derived populations have been shown with pauciarticular (DR5 (11) , DR8, and DP2(DPB1*0201)); RF negative polyarticular JA (DR5(11), DR8, and DP3(DPB1*0301)); and RF positive polyarticular JA (DR4). In a limited study, African-Americans and Mexican-Americans had similar associations to Europeans in contrast to what has been reported for other ethnic groups (for example, Asians). 11 Some evidence exists that a second DR or DQ gene may increase risk. For example, the combination of DR5/DR8 was found more often than expected in patients. 12 Aside from HLA-A2, the only other class I locus to be identified is HLA-B27, which is prevalent in older pauciarticular patients whose disease progresses to spondyloarthropathy and in other JIA patients that may carry a poor prognosis. [13] [14] [15] HLA-DRB1*04, 07, DR2, and to a less significant extent, 03 have been seen as moderately protective. 16, 17 In addition, there is evidence for promoter polymorphisms in the DQA1 locus that are associated with JIA in a German population of patients. 18 However, other studies, 17 while confirming DR findings, found no evidence for a DQ predisposition. Many of the DR-DQ haplotypes are complicated by linkage disequilibrium (LD) so it is difficult to tell which is the primary association, 19 but there is some evidence that this association is because of DRB1-08*. 20 In fact, analysis of the MHC region of chromosome 6 is complicated by extended LD within this segment. 21 Aside from the current study, only one other marker association study has been performed that examined multiple markers in the MHC region in addition to specific HLA genes. Examination of 177 German early onset pauciarticular JIA patients and 261 Caucasian German controls saw no association of seven MHC region microsatellites (D6S105, D6S510, TNFa, TNFc, TNFd, and TNFe, HSP) and no greater association of D6S2447 than with the HLA alleles DQA1*0501 and DQB1*0301. 22 Moroldo et al 23 were the first group in 1998 to examine previously typed patients and their parents (101 Caucasian families) with the transmission disequilibrium test (TDT). Their TDT results established family-based associations of HLA-A2, B27, B35, DR5, and DR8 to pauciarticular onset JIA. However, no overall TDT statistic was calculated and no other subgroups were examined.
HLA allele associations have often been weak in JIA studies and dependent on the population being examined. Linkage may therefore be implied where none exists, because of population stratification. In addition, the involvement of other genes within the HLA region has not been ruled out. This study is the beginning of an attempt to use an isolated founder population (Finnish) to more thoroughly investigate the presence of susceptibility loci on chromosome 6. Founder populations are more likely to have fewer susceptibility genes present in initial founders and to have larger regions of LD. These characteristics can make studies utilizing founder population more powerful in their ability to find susceptibility loci. The current Finnish population (B5 million) arose from a limited number of founders about 2000-2500 years ago. This initial founding population has undergone several bottlenecks, the most recent being a fall to 250 000 people in the early 18th century making it an excellent isolated founder population. 24, 25 In this study, we used conventional case-control statistics as well as the TDT, a family-based association test that is dependent on linkage and LD between alleles tested and the susceptibility locus, to examine the DRB1 locus and 16 polymorphic markers spanning the MHC. Our study population included both pauciarticular onset and polyarticular onset RH-negative probands of Finnish origin. We also examined the haplotypes of markers associated with disease in an attempt to clarify the relation between the two subtypes of disease and susceptibility to JIA in Finland.
Results

Onset and association
When the patient groups were subdivided by age of onset, the associations observed were much stronger for patients of early onset (o6 years) rather than late onset (46 years), although association was present to some extent in late onset patients (see Table 1 ). Given that the late onset group of patients is relatively small and their association may be complicated by the inclusion of different disease subtypes, 1 the observations here will be limited to the early onset patients and their subclassification into pauciarticular and polyarticular RF-negative disease (hereafter referred to as polyarticular).
Marker associations
We examined case-control associations by both allele and genotype at each of the 16 marker loci (Table 1 and  see Web Tables a and b [http://roweprogram.ucdavis. edu/Juvenile_Rheumatoid_Arthritis.pdf]). Within the 20 cM region covered by these markers, there are two associated subdivisions. The strongest of these is the region spanned by D6S2446 through MID104 in the proximal region of 6p21.3. For both subtypes of disease, polyarticular and pauciarticular, D6S2447 (formerly known as DQCAR) and D6S2446 (formerly known as DQCAR2) were strongly associated (Po10
À6
). The MID108 and MID104 markers that lie 75-77 kb distal of D6S2447 were very strongly associated with only polyarticular disease (Po5 Â 10 À5 for both genotypic and allelic association). Continuous association also extended in polyarticular patients to D6S273, a microsatellite located 785 kb proximal to D6S2447.
A second region of association was suggested in the segment bounded by markers D6S461 and D6S306 located 4500-9600 kb proximal to D6S2447. However, the associations are marginal and primarily confined to the genotype. The strongest association in this region was in the polyarticular group of patients with D6S464 (Po10 À2 by both allele and genotype).
Marker TDT
The results of the marker-by-marker allele and genotype associations are mirrored by the results of our locus-bylocus TDT analysis ( for both), MID108, and MID104 markers (P ¼ 0.008 and 0.013, respectively). TDT association is also extended telomeric in the polyarticular group to the D6S273 locus (P ¼ 0.023). In the second region showing possible association in the case-control analysis, the only locus that remained significant in the TDT was D6S464 that was most suggestive for the combined early onset subtypes (P ¼ 0.005). This locus showed marginal significance in the TDT for both the pauciarticular and polyarticular groups of patients (P ¼ 0.035 and 0.02, respectively). TNFc is a biallelic microsatellite locus that showed no evidence of association by standard case-control methods but showed some evidence using the locus TDT in the combined group (P ¼ 0.009) and tended to significance in the subgroups (see Tables 2 and 3 ).
For those markers that were significant by locus TDT, allelic association, and genotypic association, odds ratios and their 95% confidence limit were calculated (Table 4 ). In addition, the TDT was also performed for each allele to determine the alleles responsible for the differences in association (see Web 
Polyarticular vs pauciarticular
The power of the TDT and association analyses are decreased in the pauciarticular subgroup because of the smaller number of families available for analysis compared with the polyarticular subgroup. Therefore, it is possible that the MID108 and MID104 associations by allele, genotype, and TDT are strong in polyarticular probands relative to pauciarticular probands only because of the increased number of probands and families examined. This concern was addressed by randomly sampling an equal number of polyarticular probands as the number of pauciarticular probands. This new data set was examined for case-control association by allele and by genotype at the MID104 locus. This procedure was repeated 100 times for the MID104 locus and we found that the difference between the pauciarticular subgroup and polyarticular group remained (mean Po10 À5 for both allele and genotype associations; range ¼ 0.000042-0.0000004).
Haplotype examination
While the association seen at the D6S2446 and D6S2447 microsatellites is strong, haplotypic association was also examined to provide another measure of the extent of the association in the MHC class II region and in the D6S464 region. No combination of adjacent two or three markers that did not include one of the markers inside of D6S273-MID104 region was significantly associated (P40.05) (data not shown). Figure 1 shows significant two locus haplotype associations that were found among all markers examined (Po0.001). No significant two locus haplotype case-control associations were found in the early onset pauciarticular subtype. However, the polyarticular group showed an extended range of two locus haplotype associations. Haplotype association included the segment between D6S2447 and D6S497 and between as far distally as we examined (D6S1616) and as far proximally as TNFc in combination with MID104.
DRB1 association and TDT
The DRB1 locus was very strongly associated by allele, genotype, and locus TDT (for polyarticular Po10 À5 and for pauciarticular Po10 À3 for case-control association and for polyarticular P ¼ 0.000007 and for pauciarticular P ¼ 0.0231 for TDT) ( Tables 1 and 2 ). The OR and allelic , respectively). In pauciarticular probands, the DRB1*11 subclass was also associated and transmitted in excess (OR ¼ 2.7 [95% CI 1.2-6.3], TDT P ¼ 0.034) although the frequency of this allele was lower in the population (4.2% DRB1*11 in control subjects vs 13.5% DRB1*08 in control subjects). The DRB1*12 subclass (which is related to DRB1*11) was not present in the control. population and, although it showed slight transmission distortion in polyarticular patients, the overall frequency was very low in this group (1.7% of haplotypes). On the other hand, DRB1*15 showed a very low odds ratio and was not transmitted as often as expected to the polyarticular group of patients (1.7% vs 12.5%; OR ¼ 0.1 [95% CI 0.0-0.4], TDT Po0.001 after correction for compensatory decrease because of overrepresented alleles (see materials and methods)). DRB1*04, although the odds ratio is not significant, was transmitted less frequently to probands than expected in both subgroups (TDT P ¼ 0.039 and 0.014 for pauciarticular and polyarticular groups, respectively).
DRB1 allele examination
Subsequent to our results from analysis of the DRB1 locus, we chose to examine the sequence of the putative susceptibility and protective alleles for DRB1. Table 6 shows the amino-acid sequence of the third hypervariable region of the DRB1 molecule. It is in this region that the DRB1*08 and DRB1*11 subclasses share a nonconservative phenylalanine substitution. This substitution is the only region that is unique to these two subclasses within the DRB1 gene coding sequence. In addition, it is in this region that the DRB1*15 subclass has a unique nonconservative alanine substitution.
Discussion
The current data are consistent with the Finnish pauciarticular and polyarticular patients sharing HLA-DRB1 in common as a susceptibility locus. The DRB1*0801 allele was the most strongly and uniformly associated allele across both subtypes and our sequencebased typing of the locus did not reveal any diseasespecific mutations in proband samples. The fact that other related DRB1 alleles are less strongly associated with disease (DRB1*11 in pauciarticular patients) is not inconsistent with this idea.
Of potential importance, pauciarticular disease was more strongly associated with the DRB1*11 than polyarticular disease. The difference between DRB1*08 and DRB1*11 (DR5 specificity) is unlikely to be sufficient to understand why the DRB1 polyarticular disease association appears to be restricted to DRB1*08. A single 
Amino-acid position is indicated in reference to start codon. Dashed line indicate identity to the reference DRB1*0801 sequence.
conservative amino-acid difference (alanine vs leucine) is present in the critical third hypervariable region. An alternate explanation is that additional loci that modify the effects of the DRB1 locus are present and different on the haplotypes of a given DRB1 allele. For example, DRB1*08 and DRB1*11 may be sufficient for the HLA contribution to pauciarticular disease whereas for polyarticular disease additional modifying loci, in a particular DRB1*08 haplotype may also be required. There is also evidence for a protective effect of specific DRB1 alleles. After correction for the increased frequency of DRB1*08, DRB1*15 was found at a smaller frequency and was transmitted less often to probands in polyarticular JIA. It is possible that protective alleles at the DRB1 locus (and other HLA loci) abrogate the synergistic effects of other susceptibility loci. It may be important that DRB1*15 does have a nonconservative amino-acid substitution within the third hypervariable region (see Table 6 ), which may explain some of its protective effects. DRB1*15 is unique in this respect because no other subclass contains unique nonconservative changes within the third hypervariable region. This region of the DRB1 molecule is involved in the binding of antigen and recognition by the trimolecular complex.
Strong evidence exists for the association of the DRB1 locus with other immune-mediated diseases such as RA and type I diabetes. As in RA where the DRB1*04 subclass of alleles contains a strongly associated 'shared epitope', 26 we have proposed a shared epitope unique to JIA pauciarticular and polyarticular disease. This epitope is different from the RA shared epitope but contains a unique nonconservative substitution (phenylalanine) different from any other DRB1 allele. This epitope may be critical to the formation of the trimolecular complex.
It should be noted that in addition to DRB1, there are a large number of other genes with demonstrated or proposed immune-mediated activity that are in strong LD in the MHC region with the locus where we have shown strong association for both pauciarticular and polyarticular disease (bracketed by the TNFc microsatellite proximally and the MID104 locus distally). This region includes genes involved in immune signaling and inflammation (TNF, LTB, AIF1, and HSPA1L), in innate immunity (C2, BF, and C4B), and in antigen processing (TAP1, TAP2, and LMP7). Given the strength of association seen in our data for the DRB1 locus and the proposed epitope being consistent with the disease model at this locus, we believe that DRB1 is most likely important as a susceptibility locus for JIA.
We chose to focus this study on the early onset groups of patients. However, the associations of late onset patients, both pauciarticular and polyarticular, did show very weak associations that were similar in nature to those found in early onset patients. Owing to the limited number of patients, we were not able to identify particular alleles that were statistically over-represented in this group. Pending the expansion of this patient group, we would propose that this group of patients shares some of the susceptibility loci with the early onset patients but differs in the complement of other modifying susceptibility loci.
The data from the TNFc locus demonstrate an interesting caution for using the TDT. Normally, casecontrol association studies are considered to be far more powerful than studies using TDT within nuclear families because of the number of probands and controls that can be clearly genotyped in such a study. However, association studies are subject to false-positive results because of inadvertent stratification in either the control or proband pools. The data of our TNFc locus may change this consideration for some situations. If the associated allele is very frequent in the population (particularly for a biallelic marker) the overall allele frequencies may not be significantly different, but the disequilibrium in transmission can be significant. Transmission disequilibrium (ie the biased transmission of one allele over the other to affected probands) may then reflect only a 1-2% difference in the frequency of alleles between control and patient populations overall, but they may comprise up to 20% of transmissions from heterozygous parents to affected probands. In this case, the TDT is a more powerful test. This situation may be present if the true disease locus in question has a small genotypic risk ratio or is weakly linked to the true disease locus (as we believe it is here).
Interestingly, we found in this study a strong difference between early onset pauciarticular and polyarticular patients. For pauciarticular disease, only DRB1, D6S2447 and D6S2446 and haplotypes including these loci showed significant association. There were no significant case-control haplotype associations (Po0.001) even with close markers such as MID108, that is 75 kb centromeric to D6S2447 (see Table 1 ). The polyarticular group of patients showed strong association with a much more extensive region that spans MID104/MID108 and extends 800 kb telomeric to D6S273. Moreover, two locus haplotypes with significant association (Po0.001) for the polyarticular probands extend proximally over 900 kb to the TNFc microsatellite and centromeric for the MID markers as far as we genotyped at the D6S1616 microsatellite, a distance of over 11 000 kb (10 cM) (Figure 1) .
A recent study has found additional evidence that persistent and extended pauciarticular diseases (or oligoarthritis as defined by the International League of Associations for Rheumatology) are immunologically distinct subtypes as well. We did not separate these groups in this study. Their distinction may have helped to strengthen association in pauciarticular onset patients and to clarify the differences between pauciarticular and polyarticular courses of disease. 27 In an attempt to assess the effect of the MHC in patients who did not possess the DRB1 JIA epitope, we stratified our data by removing pauciarticular families with DRB1*08-positive probands and polyarticular families with DRB1*08 and DRB1*11 probands. While the number of probands became small in this stratification (19 pauciarticular and 27 polyarticular probands), the analysis indicated that the class two region was still important in these polyarticular patients (P ¼ 0.031 for DRB1, P ¼ 0.001 for D6S2446, and P ¼ 0.0025 for D6S2447). DRB1*01 was the over-represented allele subclass in these probands and showed evidence for biased transmission in the TDT (P ¼ 0.0029). We believe that the association of DRB1*01 in these patients may be because of LD with other polyarticular susceptibility loci in this region. The most likely candidates would be the HLA-DPB1 or HLA-DQA1 genes. Both of these loci have shown association with JIA subtypes (see review in Glass and Giannini
3
) but for only DQA1 has a disease-specific mutation been proposed as a possible etiology for JIA. 18, 28 As an extension of these studies, we are currently typing HLA-DPB1 and a number of additional closely linked markers.
In the MHC region, a second locus for susceptibility is suggested by the statistically significant, although less strong, association of the D6S464 microsatellite (the 208 bp allele in particular) with polyarticular disease. However, this locus is not associated as part of a haplotype with the DRB1 gene or any of the markers surrounding the DRB1 locus that showed positive association with polyarticular disease. This may indicate that the D6S464 locus is linked to a susceptibility locus that is independent of the DRB1 susceptibility, but it may also result from a lack of statistical power to resolve haplotype associations with these very highly polymorphic loci. The association of the D6S464 locus may be because of linkage with the HLA-A2 gene that has been suggested as a susceptibility locus in previous studies. 29, 30 However, the D6S464 locus is over 5 Mb telomeric of HLA-A2. Since no closer microsatellites showed association in this study, association of D6S464 more likely indicates the presence of an additional JIA susceptibility locus. We did not type the HLA-A locus and cannot demonstrate independence from that locus here, but similar evidence for additional susceptibility loci close to HLA-A2 has been found recently using the D6S265 microsatellite in a Norwegian cohort of JIA patients. 31 The difference in association between the pauciarticular and polyarticular subtypes of JIA was not because of differences in statistical power. Therefore, this difference may be because of one of three possibilities: (1) the polyarticular group of JIA patients contains more susceptibility loci in this region of the chromosome than do pauciarticular probands; (2) the pauciarticular and polyarticular JIA subgroups have a different MHC variant, that is a disease susceptibility factor; or (3) the two subtypes are the result of separate founder events and linkage between shared susceptibility loci has decayed differently in the two subtypes. The second possibility, while not excluded, is unlikely since DRB1*08 is associated with both subtypes of disease and the local haplotype (including D6S2446 and D6S2447) associated is also the same. Similarly, the third possibility appears unlikely since it would require that the original founding events not only occurred separately for pauciarticular and polyarticular disease but that they have remained separated. The grandparents of the JIA probands in this study cannot be separated geographically based on proband subtype (data not shown). Given the population history of settling in Finland, it is unlikely that such a division has ever existed and cannot have been maintained in the probands of this study, although this would require more detailed genealogical analysis. We therefore favor the first explanation that additional susceptibility loci in the extended MHC are required to generate the polyarticular subtype of disease. According to our hypothesis, the polyarticular probands would have a second gene in LD with DRB1 in the Finnish population that is not necessary for pauciarticular disease. Additional studies in an expanded cohort of Finnish JIA patients are currently addressing other potential susceptibility genes within and outside the MHC.
Materials and methods
Patient and control samples DNA samples from Finnish proband trios and controls were obtained and prepared from buccal cell swabs or extracted from peripheral blood as previously described. 32 All samples were quantified in microtiter trays using a PicoGreen fluorescence assay (Molecular Probes).
Samples of JIA patients were collected at the Rheumatism Foundation Hospital in Finland. The Rheumatism Foundation Hospital receives patients from all the five university hospitals in Finland as well as from the remaining 16 central hospital districts and also directly from primary care clinics in the entire country, but particularly in the middle-eastern region where the hospital is located. It is estimated that about two-thirds of all Finnish JIA patients are seen at the Rheumatism Foundation Hospital at some time. Only those constantly monitored by the Rheumatism Foundation Hospital were selectively included in this study series. This group consisted of 235 patient samples (233 probands and one concordant sib pair) and 393 parent samples (184 fathers and 209 mothers) as well as samples from 57 siblings. Of the probands, 57 were male and 178 were female and 150 had onset of disease symptoms before the age of 6 years. The 82 pauciarticular onset and 153 polyarticular RFnegative onset probands were classified according to the criteria of Brewer et al. 33 Probands all tested negative for RF and HLA-B27-positive individuals were excluded from analysis. Finnish control individuals were all 65+ years of age, randomly selected from the population and with no history of JIA or RA.
The ethics committee of the Rheumatism Foundation Hospital approved this study and the patients/parents gave informed consent to participate in the study.
Marker selection
Markers were selected that would span an approximately 20 cM section of chromosome 6 that included all MHC class I and class II loci. An attempt was made to maximize the potential information content available in each marker by considering its previous use in related studies, its maximum heterozygosity score, and tested ease of amplification and scoring. A total of 14 microsatellites (D6S461, D6S299, D6S464, D6S478, D6S1558, D6S306, TNFc, D6S273, D6S2446, D6S2447, D6S497, D6S291, D6S1641, and D6S1616) and two short insertion/deletion polymorphism (SIDP) (MID108 and MID104) markers were selected. Primer sequences for the DS microsatellites are as indicated in the Genome Database (http://www.gdb.org/gdb/) and that for the MID markers were as described by Marshfield Genetics (http://research.marshfieldclinic.org/genetics/). Primer sequences for the D6S2447 pair of markers were synthesized as described in Lin et al.
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PCR PCR amplification for all markers was performed in 384-well plates for 30 cycles using 0.5 ml PCR buffer, 0.7 ml 2.5 mM dNTP mix (Pharmacia & Upjohn), 0.05 ml cDNA polymerase (Clonetech Advantage), 0.1 ml 10 mM flourescently labeled primer mix, 2.65 ml double distilled H 2 O, and 1 ml 0.2 mg/ul genomic DNA for a 5 ml total reaction volume. DS microsatellites were amplified according to optimal conditions defined by Research Genetics. Reactions were placed in a PE 9700 thermal cycler for 2 min at 951C; 30 cycles of 45 s at 941C, 45 s at 571C, and 1 min at 721C; and a final extension of 7 min at 721C. TNFc amplification conditions (modified from Udalova 35 ) were 3 min at 951C; 30 cycles of 30 s at 941C, 1 min at 601C, and 1 min at 721C; and a final extension of 10 min at 721C. MID markers were amplified with optimal PCR conditions described by Marshfield (http://research. marshfieldclinic.org/genetics/). D6S2447 markers were amplified according to Lin et al.
Genotyping PCR amplified product (B0.5 ml) of each marker was run on the ABI 3700 DNA Analyzer. Genotyping was performed using analysis software provided (GeneScan and Genotyper from Perkin Elmer/ABI).
DRB1 typing
The DRB1 locus was typed using AlleleSEQR HLA-DRB1 Sequencing-Based typing kit (Forensic Analytical, Hayward, CA 94545, USA) according to the manufacturer's instructions for the ABI 3700 DNA Analyzer. This method directly sequences exon 2. Sequence analysis was performed using the supplied ABI software (SeqEd, Matchtools, and MT Navigator). Odds ratios (ORs) were calculated by the MantelHaenszel odds ratio and 95% confidence interval compiled on the internet (http://www.medepi.org/ epitools/rfunctions/ormh.html). Analysis by TDT was performed using FBAT. 37, 38 DRB1 alleles found to be significantly decreased by w 2 (data not shown) were adjusted for compensatory decrease because of overrepresented alleles and reanalyzed by w 2 . 16 Haplotype analysis was performed using the EM algorithm contained in the EH+ software. 39, 40 
Analysis
